2,912 matches for your search in the start-up spotlight

rss
matching the following criteria

image description
BioXpress Therapeutics, SA

BioXpress Therapeutics SA is a privately held biotechnology company committed to developing high quality and cost-competitive biosimilars for unmet need indications such as cancer, inflammation and autoimmunity. Headquartered in Geneva, Switzerland, BioXpress Therapeutics business is focused on ...

more

image description
GNA Biosolutions GmbH

GNA Biosolutions is a private molecular diagnostics company located in Germany. Our proprietary technology, Pulse Controlled Amplification (PCA), offers a novel, ultrafast, and cost-effective molecular diagnostic platform that captures and amplifies nucleic acids from complex clinical samples. ...

more

image description
1CryoBio AG

1CryoBio AG is a privately held company in the field of consumables for research and medical use, located at the Technopark of Lucerne in Root D4, Switzerland. 1CryoBio AG develops, produces and markets innovative plastic labware for cryogenic storage based on Danish design and Swiss quality. The ...

more

image description
Computomics GmbH

Computomics is a spin-off of the University of Tübingen and the Max Planck Institute for Developmental Biology. Computomics was founded in 2012 when it became apparent that crop companies are interested in the cutting-edge bioinformatics analyses enabled by a breakthrough in DNA sequencing ...

more

image description
akvola Technologies GmbH

akvola Technologies is a water technology company specialized in the treatment of hard-to-treat industrial wastewater with a focus in the removal of oil (free, dispersed and emulsified) and suspended solids. akvola Technologies sells custom solutions equipped with akvoFloat™ – a proprietary ...

more

image description
oncgnostics GmbH

Almost half of all men and one third of all women come down with cancer once in their lifetime. But: almost all kinds of cancer are remediable if diagnosed early. In the case of cervical cancer, diagnosed pre-stages are almost 100% curable. oncgnostics GmbH, a spin-off of the university hospital ...

more

image description
Cysal GmbH

Cysal GmbH uses an in­ter­na­tion­ally patented, biotech­no­log­i­cal process to pro­duce argininea­s­par­tate and ly­sine-as­par­tate dipep­tides on an in­dus­trial scale. The biotech­nol­ogy com­pany uses these dipep­tides, a com­bi­na­tion of two amino acids, as the base ma­te­r­ial for the ...

more

Page 288 From 292
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE